Class information for:
Level 1: MTUS1//ATIP//INVERSE PROBABILITY OF TREATMENT WEIGHT

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
15849 619 42.5 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
132 22818 ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 MTUS1 Author keyword 14 100% 1% 7
2 ATIP Author keyword 3 50% 1% 4
3 INVERSE PROBABILITY OF TREATMENT WEIGHT Author keyword 2 67% 0% 2
4 MTSG1 Author keyword 2 67% 0% 2
5 INSERMU541 Address 2 43% 0% 3
6 ACE ID Author keyword 1 50% 0% 2
7 INHIBITORS OF ANGIOTENSINOGEN CONVERTING ENZYME Author keyword 1 100% 0% 2
8 ANGIOTENSIN II TYPE I RECEPTOR Author keyword 1 18% 1% 7
9 AGT GENE Author keyword 1 25% 0% 3
10 PTKS Author keyword 1 33% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 MTUS1 14 100% 1% 7 Search MTUS1 Search MTUS1
2 ATIP 3 50% 1% 4 Search ATIP Search ATIP
3 INVERSE PROBABILITY OF TREATMENT WEIGHT 2 67% 0% 2 Search INVERSE+PROBABILITY+OF+TREATMENT+WEIGHT Search INVERSE+PROBABILITY+OF+TREATMENT+WEIGHT
4 MTSG1 2 67% 0% 2 Search MTSG1 Search MTSG1
5 ACE ID 1 50% 0% 2 Search ACE+ID Search ACE+ID
6 INHIBITORS OF ANGIOTENSINOGEN CONVERTING ENZYME 1 100% 0% 2 Search INHIBITORS+OF+ANGIOTENSINOGEN+CONVERTING+ENZYME Search INHIBITORS+OF+ANGIOTENSINOGEN+CONVERTING+ENZYME
7 ANGIOTENSIN II TYPE I RECEPTOR 1 18% 1% 7 Search ANGIOTENSIN+II+TYPE+I+RECEPTOR Search ANGIOTENSIN+II+TYPE+I+RECEPTOR
8 AGT GENE 1 25% 0% 3 Search AGT+GENE Search AGT+GENE
9 PTKS 1 33% 0% 2 Search PTKS Search PTKS
10 ACEI ARBS 1 50% 0% 1 Search ACEI+ARBS Search ACEI+ARBS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANGIOGENIC INHIBITOR 15 68% 2% 13
2 ANTI ANGIOGENIC ACTIVITIES 12 75% 1% 9
3 RECEPTOR A1166C POLYMORPHISMS 8 100% 1% 5
4 CANDESARTAN COMBINATION THERAPY 6 80% 1% 4
5 GENE INSERTION DELETION POLYMORPHISM 6 32% 3% 16
6 MURINE HEPATOCELLULAR CARCINOMA 6 58% 1% 7
7 TUMOR ASSOCIATED ANGIOGENESIS 4 28% 2% 12
8 AMINOPEPTIDASE A EXPRESSION 3 57% 1% 4
9 A1166C POLYMORPHISMS 3 100% 0% 3
10 KERATINOCYTE CANCER PREVENTION 3 100% 0% 3

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The renin-angiotensin system meets the hallmarks of cancer 2015 1 39 72%
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review 2012 19 33 73%
Angiotensin inhibition and malignancies: a review 2009 31 72 85%
The renin-angiotensin system and cancer: old dog, new tricks 2010 90 187 47%
Renin-angiotensin system and urological cancers 2014 2 54 78%
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration 2011 44 39 33%
The renin-angiotensin system and malignancy 2008 110 127 29%
The ACE Insertion/Deletion Polymorphism and Risk of Cancer, a Review and Meta-Analysis of the Literature 2011 7 60 82%
Manipulating the angiotensin system - new approaches to the treatment of solid tumours 2006 38 101 50%
Which, if any, antihypertensive agents cause cancer? 2012 7 26 54%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 INSERMU541 2 43% 0.5% 3
2 CENT CARDIOVASC REGULAT GRP 1 50% 0.2% 1
3 CLIN SCI BLOCK B 1 50% 0.2% 1
4 CLIN UROL CHILDRENS UROL 1 50% 0.2% 1
5 CNRS UMR BIOSIT 6290 1 50% 0.2% 1
6 DIPARTIMENTO BIOL FISIOL 1 50% 0.2% 1
7 GERONT 1 50% 0.2% 1
8 INFLAMMAT IMMUNOL MED SCI 1 50% 0.2% 1
9 MED COUNCIL HUMAN REPRODUCT SCI UNIT 1 50% 0.2% 1
10 MERHEIM MED COLOGNE GEN HOSP 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000229444 OCULAR RENIN ANGIOTENSIN SYSTEM//REN 2 RAT//S PHARMACOL MOL BIOL
2 0.0000138327 SERV INTEGRATO EPIDEMIOL SISTEMI INFORMAT//HLTH HLTH SERV//CARCINOMA RENAL CELL
3 0.0000131537 AT2 RECEPTOR//COMPOUND 21//ANGIOTENSIN RECEPTORS
4 0.0000128506 EXPT ENDOCRINOL HORMONE//KHABAROVSK BRANCH MATERN CHILD WELF//NORMAL RABBIT SERUM
5 0.0000114479 NEONEUROGENESIS//METASTASIS FORMATION//BP6 TU2 FIBROSARCOMA CELLS
6 0.0000085452 ANGIOTENSIN 1 7//ANGIOTENSIN CONVERTING ENZYME 2//MAS RECEPTOR
7 0.0000069575 TELMISARTAN//ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER//CLIN TRIAL MANAGEMENTITABASHI KU
8 0.0000066892 SKELETAL MUSCLE MICROCIRCULATION//RODENT MODELS OF OBESITY//RODENT MODELS OF METABOLIC SYNDROME
9 0.0000065687 PATOL VASC NEFROL EXPT//VASC RENAL PATHOL//MED ALFREDO LANARI
10 0.0000054938 CD143//ANGIOTENSIN I CONVERTING ENZYME//TESTICULAR ACE